Antihistamines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
- Transparency Market Research
Antihistamines are a class of drugs that inhibit the action of histamine by attacking the specific cell receptors meant for histamines. Histamine is an immune substance released by body’s immune system upon attack by allergens or due to intake of histamine-deficient food, some food items also trigger their excessive production which creates immune response. Histamine attaches to specific receptors of body cells which results in symptoms such as running nose, watery eyes, pain, itching, redness, and wheezing. Antihistamines are used to relieve the symptoms of seasonal allergies, motion sickness, nausea, cold and cough, anxiety. They are also used to treat skin allergies such as urticarial. Besides being used for seasonal allergies, antihistamines are administered in case of chronic allergies or other recurring conditions.
Changing lifestyle and rise in environmental pollution are projected to increase the number of patients affected with seasonal allergies. According to the World Health Organization’s “White Book on Allergy 2011-2012”, allergic rhinitis affected 10% to 30% of the world population, while lifetime prevalence of urticarial worldwide was above 20%. High prevalence of allergies and increase in incidences among children are projected to augment the intake of antihistamines during the forecast period. Antihistamines are inexpensive and some of them are also available as an over-the-counter medicine. They are preferred as the initial line of treatment for various allergies such as hay fever as they offer quick relief and have low side-effects. These factors are projected to drive the expansion of the global antihistamines market. However, most of these drugs are off-patent and have attracted several small and large-scale generic players, thereby resulting in intense price competition and devaluation of the market.
The global antihistamines market can be segmented based on dosage form, access, distribution channel, and region. In terms of dosage form, the global antihistamines market can be divided into tablets & capsules, liquids, injectable, nasal sprays, and eye drops. The tablets & capsules segment is projected to account for the dominant share of global antihistamines market owing to their low cost, ease of administration, and convenience in storage. In terms of access, the global antihistamines market can be classified into prescription-based and over-the-counter (OTC) antihistamines. Major companies are striving to switch their antihistamines drugs from prescription-based to over-the-counter availability, which is estimated to boost the growth of the OTC segment. Based on distribution channel, the global antihistamines market can be segregated into hospital pharmacies, retail pharmacies, drug stores, and online pharmacies. The retail pharmacies segment is anticipated to account for a prominent share in the global antihistamine market during the forecast period.
Geographically, the global antihistamines market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is estimated to constitute a prominent share of the global market during the forecast period, owing to high price of antihistamines in this region and also rise in the trend of self-medication. Moreover, high prevalence of allergic conditions in this region is estimated to propel the antihistamines market. Europe is anticipated to account for a significant share of the global market during the forecast period. According to the European Academy of Allergy and Clinical Immunology, around 100 million people in Europe suffer from allergic rhinitis. Increase in health care expenditure in Asia Pacific is projected to fuel the expansion of the antihistamines market during the forecast period.
Major players operating in the global antihistamines market are Bayer AG, Almirall S.A., Meda Consumer Healthcare Inc., AstraZeneca AB, Johnson & Johnson, Novartis AG, Sanofi SA, Pfizer, Inc., Boehringer Ingelheim GmbH, Akorn, Inc., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd. and others.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Pharmaceutical
PharmaceuticalChinese Markets for Mental Illness Drugs
PharmaceuticalChinese Markets for Anti-Dermatomycosis Skin Drugs
PharmaceuticalChinese Markets for Incretion Drugs
PharmaceuticalChinese Markets for Hypertension Drugs
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017